These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 17662090)

  • 1. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.
    Schwedhelm E; Maas R; Freese R; Jung D; Lukacs Z; Jambrecina A; Spickler W; Schulze F; Böger RH
    Br J Clin Pharmacol; 2008 Jan; 65(1):51-9. PubMed ID: 17662090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men.
    Ochiai M; Hayashi T; Morita M; Ina K; Maeda M; Watanabe F; Morishita K
    Int J Cardiol; 2012 Mar; 155(2):257-61. PubMed ID: 21067832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.
    Bode-Böger SM; Böger RH; Galland A; Tsikas D; Frölich JC
    Br J Clin Pharmacol; 1998 Nov; 46(5):489-97. PubMed ID: 9833603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
    J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
    Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
    J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
    Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
    Böger RH; Bode-Böger SM; Thiele W; Junker W; Alexander K; Frölich JC
    Circulation; 1997 Apr; 95(8):2068-74. PubMed ID: 9133517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral L-arginine improves endothelial function in healthy individuals older than 70 years.
    Bode-Böger SM; Muke J; Surdacki A; Brabant G; Böger RH; Frölich JC
    Vasc Med; 2003 May; 8(2):77-81. PubMed ID: 14518608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant status.
    Jabecka A; Ast J; Bogdaski P; Drozdowski M; Pawlak-Lemaska K; Cielewicz AR; Pupek-Musialik D
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1665-74. PubMed ID: 23161038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Citrulline dilates rat retinal arterioles via nitric oxide- and prostaglandin-dependent pathways in vivo.
    Mori A; Morita M; Morishita K; Sakamoto K; Nakahara T; Ishii K
    J Pharmacol Sci; 2015 Apr; 127(4):419-23. PubMed ID: 25953269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
    Doshi S; McDowell I; Goodfellow J; Stabler S; Boger R; Allen R; Newcombe R; Lewis M; Moat S
    Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells.
    Winnica D; Que LG; Baffi C; Grasemann H; Fiedler K; Yang Z; Etling E; Wasil K; Wenzel SE; Freeman B; Holguin F
    Clin Exp Allergy; 2017 Feb; 47(2):190-199. PubMed ID: 27562295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
    Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
    J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined L-citrulline and glutathione supplementation increases the concentration of markers indicative of nitric oxide synthesis.
    McKinley-Barnard S; Andre T; Morita M; Willoughby DS
    J Int Soc Sports Nutr; 2015; 12():27. PubMed ID: 26097441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
    J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Arginine is related to endothelium-dependent vasodilation in resistance and conduit arteries in divergent ways-The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
    Lind L; Larsson A; Teerlink T
    Atherosclerosis; 2009 Apr; 203(2):544-9. PubMed ID: 18757055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
    Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
    Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-arginine does not improve biochemical and hormonal response in trained runners after 4 weeks of supplementation.
    Alvares TS; Conte-Junior CA; Silva JT; Paschoalin VM
    Nutr Res; 2014 Jan; 34(1):31-9. PubMed ID: 24418244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition.
    Kielstein JT; Simmel S; Bode-Böger SM; Roth HJ; Schmidt-Gayk H; Haller H; Fliser D
    Kidney Blood Press Res; 2004; 27(3):143-7. PubMed ID: 15192321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.